Search Orphan Drug Designations and Approvals
-
Generic Name: | (2S,3S,4E,6S,7R,10R)-7,10-Dihydroxy-3,7-dimethyl-12-oxo-2-[(2E,4E,6R)-6-(pyridin-2-yl)hepta-2,4-dien-2-yl]oxacyclododec-4-en-6-yl 4-methylpiperazine-1-carboxylate |
---|---|
Date Designated: | 06/22/2017 |
Orphan Designation: | Treatment of chronic myelomonocytic leukemia (CMML) |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Pharmavant 7 Sciences GmBH Viaduktstr. 8 Basel 4051 Switzerland The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-